Expertise in all things FDA
Menu
News & Events
This just in
Expertise in all things FDA
Lisa Harrington
- Congratulations to HP&M’s first Principal Medical Device Regulation Expert, Adrienne LenzJanuary 6th, 2022
January 6, 2022 Hyman, Phelps & McNamara, P.C. (HP&M) is pleased to announce Adrienne R. Lenz has become its first Principal Medical Device Regulation Expert. Adrienne joined HPM in September 2017. In her time with HPM, she has made significant contributions to the firm and its clients. Prior …
- HP&M Promotes Sara Koblitz to DirectorJanuary 6th, 2022
January 6, 2022 Hyman, Phelps & McNamara, P.C. (HP&M) is pleased to announce that Sara W. Koblitz has become the firm’s newest Director. Sara’s practice covers the intersection of FDA regulatory issues and Intellectual Property, including the Hatch-Waxman Amendments, the Biologics Price Competition and Innovation Act, and the …
- Kurt Karst is Co-Chair of ACI’s FDA Boot Camp (Virtual Event)December 28th, 2021
- Kurt Karst is speaking at ACI’s Paragraph IV Disputers ConferenceNovember 9th, 2021
- Kurt Karst is speaking at AAM’s Generic + Biosimilars ConferenceNovember 8th, 2021
- Allyson Mullen is speaking at AMDM’s Focus MeetingOctober 8th, 2021
- Jeff Gibbs is speaking at AMDM’s Focus MeetingOctober 1st, 2021
- Kurt Karst is speaking at ACI’s FDA Boot CampAugust 31st, 2021
- Adrienne Lenz is Speaking on RAPS Wisconsin Chapter WebcastJune 16th, 2021
- Jeff Gibbs is speaking at FDLI Annual Conference: Exploring Advanced Topics in Food and Drug LawMay 19th, 2021
For more information see conference website
- Anne Walsh is speaking at FDLI Annual Conference: Exploring Advanced Topics in Food and Drug LawMay 18th, 2021
For more information see conference website
- Allyson Mullen is speaking at AMDM’s Annual IVD Regulatory MeetingApril 16th, 2021
For more information see meeting website
- Riette van Laack is speaking at FDLI’s Introduction to Food Law and Regulation ConferenceMarch 16th, 2021
For more information see conference website
- Serra Schlanger is speaking at FDLI’s Introduction to Medical Device Law and Regulation ConferenceMarch 2nd, 2021
For more information see conference website
- Deborah Livornese is speaking at the ACI Legal, Regulatory & Compliance Forum on Over the Counter DrugsFebruary 26th, 2021
For more information contact conference website
- James Valentine is a moderator at Jett Foundation Celebrating Rare Disease DayFebruary 26th, 2021
For more information see conference website
- Frank Sasinowski is a panelist in Wow or Yeow?! FDA Outlook for 2021 and Beyond WebinarJanuary 29th, 2021
For more information or to register for webinar, click here
- Serra Schlanger is speaking at George Mason University Scalia Law School Law & Economics Center (LEC) Virtual one-day micro-symposium on “Emerging Issues in the Economics and Law of Pharmaceutical RegulationJanuary 22nd, 2021
For more information, see conference website
- Adrienne Lenz is speaking at RAPS Wisconsin Chapter WebcastJanuary 13th, 2021
For more information see conference website
- Anne Walsh is speaking at FDLI’s Enforcement, Litigation and Compliance Conference: For the Drug, Device, Food and Tobacco Industries(Virtual Event)December 15th, 2020
For more information see conference website
- Larry Houck is speaking at FDLI’s Legal and Practical Issues in the Evolving World of Cannabis Regulation ConferenceDecember 8th, 2020
For more information see conference website
- Serra Schlanger is speaking at CTeL Fall 2020 Digital Health SummitDecember 1st, 2020
For more information see conference website
- Anne Walsh is speaking at IBA 2020 – Virtual Together ConferenceNovember 23rd, 2020
For more information see conference website
- HP&M Announces that Sara Koblitz has been Promoted to Counsel at the FirmNovember 18th, 2020
Hyman Phelps & McNamara, P.C. is pleased to announce that Sara Koblitz has been promoted to Counsel at the firm. Sara joined HPM in 2017 and advises clients on a broad range of FDA regulatory issues with a particular focus on Hatch-Waxman patent and exclusivity, biosimilars, and the …
- Serra Schlanger is speaking at InformaConnect’s Drug Pricing Transparency Congress (Virtual Event)November 16th, 2020
For more information see conference website
- HP&M Takes Home “Law Firm of the Year” Award from U.S. News and Best LawyersNovember 13th, 2020
Hyman, Phelps & McNamara, P.C. (“HP&M”) has been named the FDA Law “Law Firm of the Year” by the folks over at U.S. News & World Report, who teamed up with Best Lawyers for the 2021 “Best Law Firms” rankings. We’re truly honored! But the honors …
- Jeff Gibbs is speaking at FDLI’s Food and Drug Law Journal 2020 Symposium: This Teachable Moment: How COVID-19 Provides Lessons from FDA’s Past and Present That Will Benefit Its Future PreparednessNovember 12th, 2020
For more information see conference website
- Kurt Karst is speaking at ACI’s Life Sciences IP Due Diligence Conference (Virtual Event)November 10th, 2020
For more information see conference website
- Jeff Gibbs is speaking at AMDM IVD Focus Meeting, VirtualOctober 16th, 2020
For more information see conference website
- Anne Walsh is speaking at FDLI’s 2020 Annual ConferenceOctober 8th, 2020
For more information see conference website
- Kurt Karst is speaking at ACI’s Livestream Event: Paragraph IV DisputesOctober 6th, 2020
For more information see conference website
- Jeff Shapiro is speaking at FDLI’s Virtual Event: Digital Health Technology and Regulation During COVID-19 and BeyondSeptember 10th, 2020
For more information, see conference website
- Deborah Livornese is speaking at FDLI Virtual Event, Introduction to Drugs, Biologics and Biosimilars Law and RegulationAugust 13th, 2020
For more information see conference website
- John Gilbert is speaking at ACI’s Virtual Conference: Controlled Substances – Regulation, Litigation and EnforcementJuly 21st, 2020
For more information see conference website